Acadian Asset Management
FHTX icon

Acadian Asset Management’s Foghorn Therapeutics FHTX Stock Holding History

Acadian Asset Management’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$535K Buy
151,224
+112,440
+290% +$592K ﹤0.01% 1413
2026
Q2 		$187K Buy
38,784
+1,153
+3% +$5.12K ﹤0.01% 1650
2026
Q1 		$177K Buy
37,631
+29,905
+387% +$164K ﹤0.01% 1621
2025
Q4 		$41K Buy
+7,726
New +$35K ﹤0.01% 1823
2025
Q2 		– Sell
-9,495
Closed -$34K – 1709
2025
Q1 		$34K Sell
9,495
-26,289
-73% -$120K ﹤0.01% 1482
2024
Q4 		$168K Sell
35,784
-6,583
-16% -$48K ﹤0.01% 1283
2024
Q3 		$393K Hold
42,367
– – ﹤0.01% 1144
2024
Q2 		$243K Hold
42,367
– – ﹤0.01% 1381
2024
Q1 		$283K Buy
+42,367
New +$235K ﹤0.01% 1121
2023
Q2 		– Sell
-27,085
Closed -$165K – 1787
2023
Q1 		$165K Buy
27,085
+3,544
+15% +$23.2K ﹤0.01% 1296
2022
Q4 		$149K Buy
23,541
+19,181
+440% +$145K ﹤0.01% 1354
2022
Q3 		$37K Buy
+4,360
New +$56.1K ﹤0.01% 1534

Other funds holding FHTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Acadian Asset Management's FHTX Position: Q3 2026 in Review

Acadian Asset Management increased its Foghorn Therapeutics (FHTX) stake by 290% in Q3 2026, buying an estimated $592K and bringing the position to 151,224 shares worth $535K. The position accounts for ﹤0.01% of the portfolio, ranked #1413.

Acadian Asset Management first reported a position in FHTX in Q3 2022 and has held it in 12 quarters since. 44 funds tracked by Wall St. Rank hold FHTX as of Q3 2026.

  • Acadian Asset Management held 151,224 shares of Foghorn Therapeutics worth $535K as of Q3 2026.
  • Acadian Asset Management bought 112,440 Foghorn Therapeutics shares in Q3 2026, an estimated $592K.
  • Foghorn Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q3 2026, its #1413 holding.
  • Acadian Asset Management first reported a position in Foghorn Therapeutics in Q3 2022 and has held it in 12 quarters since.
  • 44 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q3 2026.

Based on Acadian Asset Management's 13F filing for Q3 2026, filed 9 Nov 2026.